{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:05:18Z","timestamp":1770836718091,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00784-018-2688-3","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T15:31:12Z","timestamp":1539012672000},"page":"2339-2344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term scopolamine treatment and dental caries"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-6875","authenticated-orcid":false,"given":"Eran","family":"Galili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elor","family":"Averbuch Zehavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Zadik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomm","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liron","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Merdler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Kuten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dror","family":"Tal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"2688_CR1","first-page":"219","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"JH Brown","year":"2011","unstructured":"Brown JH, Laiken N (2011) Muscarinic receptor agonists and antagonists. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York, pp 219\u2013237","edition":"12"},{"key":"2688_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2165\/00003088-200645060-00001","volume":"45","author":"Z Nachum","year":"2006","unstructured":"Nachum Z, Shupak A, Gordon CR (2006) Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 45:543\u2013566","journal-title":"Clin Pharmacokinet"},{"key":"2688_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/01.ftd.0000168293.48226.57","volume":"27","author":"UD Renner","year":"2005","unstructured":"Renner UD, Oertel R, Kirch W (2005) Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 27:655\u2013665","journal-title":"Ther Drug Monit"},{"key":"2688_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/000348948809700206","volume":"97","author":"YP Talmi","year":"1988","unstructured":"Talmi YP, Finkelstein Y, Zohar Y, Laurian N (1988) Reduction of salivary flow with Scopoderm TTS. Ann Otol Rhinol Laryngol 97:128\u2013130","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2688_CR5","unstructured":"American Society of Health-System Pharmacists (2008) AHFS drug information 2008. Bethesda, MD"},{"key":"2688_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/A:1015916423156","volume":"6","author":"L Putcha","year":"1989","unstructured":"Putcha L, Cintr\u00f3n NM, Tsui J, Vanderploeg JM, Kramer WG (1989) Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res 6:481\u2013485","journal-title":"Pharm Res"},{"key":"2688_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/j.1552-4604.1985.tb02867.x","volume":"25","author":"C Gordon","year":"1985","unstructured":"Gordon C, Ben-Aryeh H, Attias J, Szargel R, Gutman D (1985) Effect of transdermal scopolamine on salivation. J Clin Pharmacol 25:407\u2013412","journal-title":"J Clin Pharmacol"},{"key":"2688_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","volume":"326","author":"P Herbison","year":"2003","unstructured":"Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 326:841\u2013844","journal-title":"BMJ"},{"key":"2688_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1476-5381.2010.01190.x","volume":"163","author":"BC Moulton","year":"2011","unstructured":"Moulton BC, Fryer AD (2011) Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. Br J Pharmacol 163:44\u201352","journal-title":"Br J Pharmacol"},{"issue":"5 Suppl","key":"2688_CR10","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.14219\/jada.archive.2008.0347","volume":"139","author":"GK Stookey","year":"2008","unstructured":"Stookey GK (2008) The effect of saliva on dental caries. J Am Dent Assoc 139(5 Suppl):11S\u201317S","journal-title":"J Am Dent Assoc"},{"key":"2688_CR11","doi-asserted-by":"publisher","unstructured":"Fedorova T, Knudsen CS, Mouridsen K, Nexo E, Borghammer P Salivary acetylcholinesterase activity is increased in Parkinson\u2019s disease: a potential marker of parasympathetic dysfunction. Parkinsons Dis 2015, 2015:156479\u2013156477. \n                    https:\/\/doi.org\/10.1155\/2015\/156479","DOI":"10.1155\/2015\/156479"},{"key":"2688_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2337\/diaspect.24.4.199","volume":"24","author":"BK Gandara","year":"2011","unstructured":"Gandara BK, Morton TH Jr (2011) Non-periodontal oral manifestations of diabetes: a framework for medical care providers. Diabetes Spectrum 24:199\u2013205","journal-title":"Diabetes Spectrum"},{"key":"2688_CR13","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.4317\/medoral.20969","volume":"21","author":"J-A Gil-Montoya","year":"2016","unstructured":"Gil-Montoya J-A, Silvestre F-J, Barrios R, Silvestre-Rangil J (2016) Treatment of xerostomia and hyposalivation in the elderly: a systematic review. Med Oral Patol Oral Cir Bucal 21:e355\u2013e366","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2688_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cden.2014.07.004","volume":"58","author":"ML Singh","year":"2014","unstructured":"Singh ML, Papas A (2014) Oral implications of polypharmacy in the elderly. Dent Clin N Am 58:783\u2013796","journal-title":"Dent Clin N Am"},{"key":"2688_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.adaj.2015.11.008","volume":"147","author":"DT Zero","year":"2016","unstructured":"Zero DT, Brennan MT, Daniels TE, Papas A, Stewart C, Pinto A, Al-Hashimi I, Navazesh M, Rhodus N, Sciubba J, Singh M, Wu AJ, Frantsve-Hawley J, Tracy S, Fox PC, Ford TL, Cohen S, Vivino FB, Hammitt KM, Sj\u00f6gren\u2019s Syndrome Foundation Clinical Practice Guidelines Committee (2016) Clinical practice guidelines for oral management of Sj\u00f6gren disease: dental caries prevention. J Am Dent Assoc 147:295\u2013305","journal-title":"J Am Dent Assoc"},{"key":"2688_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/0022034514555365","volume":"94","author":"J Cheng","year":"2015","unstructured":"Cheng J, Chaffee BW, Cheng NF, Gansky SA, Featherstone JDB (2015) Understanding treatment effect mechanisms of the CAMBRA randomized trial in reducing caries increment. J Dent Res 94:44\u201351","journal-title":"J Dent Res"},{"key":"2688_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000337241","volume":"46","author":"JDB Featherstone","year":"2012","unstructured":"Featherstone JDB, White JM, Hoover CI, Rapozo-Hilo M, Weintraub JA, Wilson RS, Zhan L, Gansky SA (2012) A randomized clinical trial of anticaries therapies targeted according to risk assessment (caries management by risk assessment). Caries Res 46:118\u2013129","journal-title":"Caries Res"},{"key":"2688_CR18","unstructured":"Central Bureau of Statistics (2016) Characterization and classification of local authorities by the socio-economic level of the population 2013. Central Bureau of Statistics, Israel"},{"key":"2688_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(07)60031-2","volume":"369","author":"RH Selwitz","year":"2007","unstructured":"Selwitz RH, Ismail AI, Pitts NB (2007) Dental caries. Lancet 369:51\u201359","journal-title":"Lancet"},{"key":"2688_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1741-2358.2002.00080.x","volume":"19","author":"JM Chalmers","year":"2002","unstructured":"Chalmers JM, Carter KD, Spencer AJ (2002) Caries incidence and increments in community-living older adults with and without dementia. Gerodontology 19:80\u201394","journal-title":"Gerodontology"},{"key":"2688_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.adaj.2015.09.014","volume":"147","author":"C-Q Cheng","year":"2016","unstructured":"Cheng C-Q, Xu H, Liu L, Wang R-N, Liu Y-T, Li J, Zhou X-K (2016) Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis. J Am Dent Assoc 147:236\u2013243","journal-title":"J Am Dent Assoc"},{"key":"2688_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1365-2125.1992.tb04078.x","volume":"33","author":"I Ziv","year":"1992","unstructured":"Ziv I, Versano D, Ruach M, Izraeli S, Almog S, Alhalel A, Alkalay M, Menahem S, Tochner Z (1992) Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine. Br J Clin Pharmacol 33:507\u2013510","journal-title":"Br J Clin Pharmacol"},{"key":"2688_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0735-1097(87)80207-3","volume":"10","author":"SL Teichman","year":"1987","unstructured":"Teichman SL, Ferrick A, Kim SG, Matos JA, Waspe LE, Fisher JD (1987) Disopyramide-pyridostigmine interaction: selective reversal of anticholinergic symptoms with preservation of antiarrhythmic effect. J Am Coll Cardiol 10:633\u2013641","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-018-2688-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T19:11:05Z","timestamp":1570475465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-018-2688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1007\/s00784-018-2688-3","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"19 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval for this study was obtained from the IDF Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}